Effect of pitavastatin on serum high-molecular weight (HMW) adiponectin to total adiponectin ratio in type 2 diabetic patients

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 4, Issue 2, 2010, Pages 95-96

  Yoshioka, Keiji ^a   Murakami, Yumi ^a   Ego, Kyoko ^a   Nakajima, Yasuhiro ^a  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Adiponection; High molecular weight; Pitavastatin

Indexed keywords

ADIPONECTIN; PITAVASTATIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 77956681652     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2010.01.002     Document Type: Article

References (20)

1. R.S. Rosenson, and C.C. Tangney Antiatherothrombotic properties of statins: implications for cardiovascular event reduction JAMA 279 1998 1643 1650
2. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 2005 89 118
3. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara cDNA cloning and expression of novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 1996 286 296
4. M.E. Trujillo, and P.E. Scherer Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome J Intern Med 257 2005 167 175
5. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451
6. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Mitsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001
7. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, and J. Miyanaga Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
8. K. Hara, M. Hirokoshi, T. Yamamuchi, H. Yago, O. Miyazaki, and H. Ebinuma Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 2006 1357 1362
9. M. Matsuda, I. Shimomura, M. Sata, Y. Arita, M. Nishida, and N. Maeda Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis J Biol Chem 277 2002 37487 37491
10. H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, and S. Kita Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin J Biol Chem 278 2003 40352 40363
11. U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, and J.P. Berger Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity J Biol Chem 279 2004 12152 12162
12. M. Fisher, M.E. Trujillo, W. Hanif, A.H. Barnett, P.G. McTernan, and P.E. Scherer Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males Diabetologia 48 2005 1084 1087
13. Y. Seino, H. Hirose, I. Saito, and H. Itoh High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men Metabolism 56 2007 1493 1499
14. Y. Aso, R. Yamamoto, S. Wakabayashi, T. Uchida, K. Takayanagi, and K. Takebayashi Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin Diabetes 55 2006 1954 1960
15. M.H. Gannagé-Yared, R.R. Azar, M. Amm-Azar, S. Khalifé, M. Germanos-Haddad, and R. Neemtallah Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients Metabolism 54 2005 947 951
16. G.K. Shetty, C.S. Mantzoros, P.A. Economides, A. Veves, and E.S. Horton Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2450 2457
17. N. Inami, S. Nomura, A. Shouzu, S. Omoto, Y. Kimura, and N. Takahashi Effects of pitavastatin on adiponectin in patients with hyperlipidemia Pathophysiol Haemost Thromb 36 2007 1 8
18. S. Nomura, A. Shouzu, S. Omoto, N. Inami, A. Tanaka, and M. Nanba Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus Thromb Res 122 2008 39 45
19. T. Hirano, Y. Ito, H. Saegusa, and G. Yoshino A novel and simple method for quantification of small, dense LDL J Lipid Res 44 2003 2193 2201
20. H. Sone, A. Takahashi, H. Shimano, S. Ishibashi, G. Yoshino, and N. Morisaki HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes Life Sci 71 2002 2403 2412